Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-06-14
2011-06-14
Lewis, Patrick T (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S024000, C514S025000, C514S028000, C536S004100, C536S013000
Reexamination Certificate
active
07960353
ABSTRACT:
Novobiocin analogues and pharmaceutical composition containing such compounds useful for the treatment and/or prevention of neurodegenerative disorders and autoimmune disorders.
REFERENCES:
patent: 5134127 (1992-07-01), Stella et al.
patent: 5376645 (1994-12-01), Stella et al.
patent: 5382572 (1995-01-01), Alfonso et al.
patent: 5874418 (1999-02-01), Stella et al.
patent: 6046177 (2000-04-01), Stella et al.
patent: 6579902 (2003-06-01), Demassey et al.
patent: 7208630 (2007-04-01), Blagg et al.
patent: 7148228 (2007-12-01), Kasibhatla et al.
patent: 7608594 (2009-10-01), Blagg
patent: 7622451 (2009-11-01), Blagg et al.
patent: 7811998 (2010-10-01), Blagg et al.
patent: 2007/0270452 (2007-11-01), Blagg et al.
patent: 2008/0146545 (2008-06-01), Winssinger et al.
patent: 2009/0163709 (2009-06-01), Blagg
patent: 2009/0187014 (2009-07-01), Blagg et al.
patent: 2010/0022635 (2010-01-01), Rajewski
patent: WO2006-050501 (2006-05-01), None
patent: WO 2010/014617 (2010-02-01), None
patent: WO 2010/096650 (2010-08-01), None
Lu et al. Bioorganic & Medicinal Chemistry (2009), vol. 17, pp. 1709-1715.
Burlison et al. (2006) J. Am. Chem. Soc. 128(48):15529-15536 (epublished on Nov. 10, 2006) “Novobiocin: redesigning a DNA Gyrase Inhibitor for Selective Inhibition of Hsp90”.
Le Bras et al. (2007) Med. Chem. 6189-6200 “New Novobiocin Analogues as Antiproliferative Agents in Breast Cancer Cells and Potential Inhibitors of Heat Shock Protein 90”.
Messaoudi et al. (2008) Med. Chem. 8:761-782 “Recent Advances in Hsp90 Inhibitors as Antitumor Agents, Anti-Cancer Agents”.
Radanyi et al. (2009) Cancer Lett. 274:88-94 “Antiproliferative and Apoptotic Activities of Tosylcylconovobiocic Acids as Potent Heat Shock Protein 90 Inhibitors in Human Cancer Cells”.
Radanyi et al. (2008) Biorg. Med. Chem. Lett. 18:2495-2498 “Synthesis and Biological Activity of Simplified Denoviose-Coumarins Related to Novobiocin as Potent Inhibitors of Heat Shock Protein 90 (Hsp90)”.
Radanyi et al. (2009) Biochem. Biophys. Res. Comm. 379:514-518 “Tosylcyclonovobiocic Acids Promote Cleavage of the Hsp90-associated Cochaperone p23”.
Shen et al. (2004) Bioorganic & Medicinal Chemistry Letters 14:5903-5906 “Syntheses of photolabile novobiocin analogues”.
Yu et al. (2004) J. Org. Chem. 69:7375-7378 “Synthesis of (−)-Noviose from 2,3-O-Isopropylidene-D-erythronolactol”.
Yu et al. (2005) J. Org. Chem. 70:5599-5605 “Synthesis of Mono- and Dihydroxylated Furanoses, Pyranoses, and an Oxepanose for the Preparation of Natural Product Analogue Libraries”.
Yu et al. (2005) J. Am. Chem. Soc. 127:12778-12779 “Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues”.
International Search Report mailed Apr. 13, 2010 re: PCT/US10/24729.
Lubbers (2005) Thesis paper submitted to the University of Kansas in partial fulfillment for the degree of Masters of Science “Synthetic and computational efforts toward the understanding and development of novobiocin-derived inhibitors of Hsp90”.
Donnelly et al. (2008) Curr. Med. Chem. 15(26):2702-2717 “Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide-binding Pocket”.
Harris et al., Syntheses of d-and I-Mannose, Glucose, and Talose via Diastereoselective and Enantioselective Dihydroxylation Reactions, Org. Chem. 2982-2983 (1999).
Haukass et al., Enantioselective Synthesis of 2-Deoxy- and 2, 3-Dideoxyhexoses, Org. Lett. 1771-1774 (2002).
Ahmed et al., De Novo Enantioselective Syntheses of Galacto-Sugars and Deoxy Sugars via the Interactive Dihydroxylation of Dienoate, Org. Lett. 745-748 (2005).
Blagg et al., Hsp90 Inhibitors: Small Molecules that Transform the Hsp90 Protein Folding Machinery into a Catalyst for Protein Degradation, Med. Res. Rev. 26 310-338 (2006).
U.S. Appl. No. 12/894/654, filed Sep. 30, 2010, Calvet et al.
Chaudhury et al., Hsp90 as a Target for Drug Development, ChemMedCherm. 1 1331-1340 (2006).
Burlison et al., Coumermycin A1 Analogues that Inhibit the Hsp90 Protein Folding Machinery, Org. Lett 8 4855-4858(2006).
Ansar et al., A Non-toxic Hsp90 Inhibitor Protects Neurons from Ab-induced Toxicity, Biorg. Med. Chem. Lett. 17 1984-1990 (2007).
International Search Report mailed Sep. 15, 2009 re PCT/US09/51972.
Setlow et al., Mechanism of Acquisition of Chromosomal Markers by Plasmids in Haemophilus influenzae, Journal of Bacteriology, 160 662-667 (1984).
Gombert et al., Susceptibility of Multiply Antibiotic-Resistant Pneumococci to the New Quinoline Antibiotics, Nalidixic Acid, Coumermycin, and Novobiocin, Antimicrobial Agents and Chemotherapy, 26 933-934 (1984).
Gebhart et al., In Vitro Activities of 47 Antimicrobial Agents Against Three Campylobacter ssp. from Pigs, Antimicrobial Agents and Chemotherapy, 27 55-59 (1985).
Burlison et al., Development of Novobiocin Analogues That Manifest Anti-proliferative Activity against Several Cancer Cell Lines, J. Org. Chem. 73(6) 2130-2137 (2008).
Donnelly et al., The Design, Synthesis, and Evaluation of Coumarin Ring Derivatives of the Novobiocin Scaffold that Exhibit Antiproliferative Activity, J. Org. Chem., 73 (22): 8901-8920 (2008).
Madhavan et al., Novel Coumarin Derivatives of Heterocyclic Compounds as Lipid-Lowering Agents, Bioorganic & Med Chem Letters 13 (2003) 2547-2551.
Marcu et al., The Heat Shock Protein 90 Antagonist Novobiocin Interacts with a Previously Unrecognized ATP-binding Domain in the Carboxyl Terminus of the Chaperone, Journal Biological Chem., 275 (2000) pp. 37181-37186.
Wells et al., A Facile Synthesis of 3-Acylaminoisocoumarins, J. Org. Chem., 36 (1971) pp. 1503-1506.
Lewis Patrick T
Merchant & Gould P.C.
University of Kansas
LandOfFree
Novobiocin analogues as neuroprotective agents and in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novobiocin analogues as neuroprotective agents and in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novobiocin analogues as neuroprotective agents and in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2696285